Diabeto

Chicago, United States Founded: 2012 • Age: 14 yrs Acquired By Livongo
Diabetes monitoring and management app along with healthcare coaches
Annual revenue $731,656 Latest available
Total funding $65,000 2 rounds
Employees 30 Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Diabeto

Diabeto is a company based in Chicago (United States) founded in 2012 was acquired by Livongo in September 2017. Diabeto has raised $65 thousand across 2 funding rounds from investors including Livongo, SOSV and HAX. The company has 30 employees as of May 31, 2023. Diabeto operates in a competitive market with competitors including Glooko, BeatO, Health2Sync, Dr. Diary Co and SocialDiabetes, among others.

  • Headquarter Chicago, United States
  • Employees 30 as on 31 May, 2023
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Diabeto Healthtech Llp
  • Date of Incorporation 17 Oct, 2016
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
    $731.66 K (USD)
    79
    as on Mar 31, 2019
  • Net Profit
    $94.11 K (USD)
    115
    as on Mar 31, 2019
  • EBITDA
    $140.9 K (USD)
    133
    as on Mar 31, 2019
  • Total Equity Funding
    $65 K (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
    Livongo

    & 3 more

  • Employee Count
    30

    as on May 31, 2023

  • Acquired by
    Livongo

    (Sep 13, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Diabeto

Diabeto has successfully raised a total of $65K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (26 Nov 2012)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2016 Amount Seed - Diabeto Valuation

investors

SOSV , HAX
Nov, 2012 Amount Seed - Diabeto Valuation

investors

Investors in Diabeto

Diabeto has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Livongo, SOSV and HAX.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital and accelerator services are provided across multiple sectors.
Founded Year Domain Location
Startups are accelerated via a 111-day program with seed funding.
Founded Year Domain Location
Government-backed startup accelerator programs are operated in Chile.
Founded Year Domain Location

Investments & Acquisitions by Diabeto

Investments

Financial Statements - Diabeto

Diabeto Comparisons

+
Add Comparison
Available on Premium

Competitors of Diabeto

Diabeto operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glooko, BeatO, Health2Sync, Dr. Diary Co and SocialDiabetes, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Diabetes management is enabled via glucose meters and mobile apps.
domain founded_year HQ Location
Smartphone-enabled glucometers and diabetes management apps are provided.
domain founded_year HQ Location
Provider of an app for tracking blood glucose level
domain founded_year HQ Location
Provider of app for diabetes management
domain founded_year HQ Location
Mobile health solution that connects doctors and diabetic patients
domain founded_year HQ Location
SaaS for Type 1 diabetes management is provided by Tidepool.

Latest news on Diabeto

Frequently Asked Questions about Diabeto

Diabeto was founded in 2012.

Diabeto is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.

Diabeto is a funded company, having raised a total of $65K across 2 funding rounds to date. The company's 1st funding round was a Seed of $65K, raised on Nov 26, 2012.

As of May 31, 2023, the latest employee count at Diabeto is 30.

Annual revenue of Diabeto is $731.66K as on Mar 31, 2019.

Diabeto offers a mobile application for monitoring and managing diabetes. Features include logging food, mood, activity, and insulin; multiple device support; analysis and tracking; and data sharing. Also, offers subscription based diet coaching from expert dieticians. It has a Bluetooth hardware device which enables the transfer of glucose readings from a Glucometer into an application on a mobile device. The Diabeto Enterprise API (cloud-based) for iOS enables third-party application developers to build mobile applications that can, using the API, communicate over Bluetooth with Diabeto to fetch readings from various supported glucometers.

Diabeto's top competitors include BeatO, Glooko and Health2Sync.

Diabeto has 4 investors. Key investors include Livongo, SOSV, HAX, and Start-Up Chile.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available